Artikel: La doxycycline ou comment faire du neuf avec du vieux ?
2014 Band 69, Heft 2, Seite(n) 129–141
Abstract: Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, ... ...
Titelübersetzung | Doxycycline or how to create new with the old?. | |||||
---|---|---|---|---|---|---|
Abstract | Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, angiogenesis, apoptosis, metal chelation, ionophoresis, and bone metabolism were studied. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade components of the extracellular matrix (ECM). MMPs have direct or indirect effects on the vascular endothelium and the vascular relaxation/contraction system. The therapeutic effects of tetracyclines and analogues were studied in rosacea, bullous dermatoses, neutrophilic diseases, pyoderma gangrenosum, sarcoidosis, aortic aneurysms, cancer metastasis, periodontitis and autoimmune diseases autoimmune diseases such as rheumatoid arthritis and scleroderma. In addition, downregulation of MMP using doxycycline could be beneficial in reducing vascular dysfunction mediated by MMPs and progressive damage of the vascular wall. We review the nonantibiotic properties of doxycycline and its potential clinical applications. |
|||||
Mesh-Begriff(e) | Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Doxycycline/pharmacology ; Doxycycline/therapeutic use ; Drug Repositioning ; Humans ; Matrix Metalloproteinase Inhibitors/pharmacology ; Matrix Metalloproteinase Inhibitors/therapeutic use ; Matrix Metalloproteinases/metabolism ; Neoplasms/drug therapy ; Neoplasms/pathology ; Periodontal Diseases/drug therapy ; Rheumatic Diseases/drug therapy ; Skin Diseases/drug therapy | |||||
Chemische Substanzen | Anti-Bacterial Agents ; Anti-Inflammatory Agents ; Matrix Metalloproteinase Inhibitors ; Matrix Metalloproteinases (EC 3.4.24.-) ; Doxycycline (N12000U13O) | |||||
Sprache | Französisch | |||||
Erscheinungsdatum | 2014-03 | |||||
Erscheinungsland | France | |||||
Dokumenttyp | English Abstract ; Journal Article ; Review | |||||
ZDB-ID | 603474-3 | |||||
ISSN | 1958-5578 ; 0040-5957 | |||||
ISSN (online) | 1958-5578 | |||||
ISSN | 0040-5957 | |||||
DOI | 10.2515/therapie/2013069 | |||||
Signatur |
|
|||||
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Ue I Zs.272: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.